Efficacy of Intranasal Corticosteroid (Fluticasone) on Adenotonsillar Hypertrophy
Phase 2
- Conditions
- Efficacy of Intranasal Corticosteroid (Fluticasone) on Adenotonsillar Hypertrophy.
- Registration Number
- IRCT20210228050524N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Children 4 to 10 Years Old With Adenotonsillar Hypertrophy
Existence Of Snoring
Existence Of Enlarged tonsils in clinical examination
Existence Of Nasal congestion
Existence Of Rhinorrhea
Exclusion Criteria
Existence Of Anatomical Abnormalities
Existence Of Neuromuscular Disease
Existence Of Upper Respiratory Tract Infections
Existence Of Allergic Rhinitis
Existence Of Recurrent Tonsillitis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adenotonsillar Hypertrophy in clinical examination and symptoms of nasal congestion, snoring, rhinorrhea. Timepoint: Two Weeks. Method of measurement: Clinically and according to the opinion of the ENT Specialist.
- Secondary Outcome Measures
Name Time Method